- How it Works
- About Us
- Global Partners
In our educational webinar, we explain how to use shear thinning analysis to assess temperature, concentration, and protein excipient levels
The viscosity of blood influences at least three variables: its ability to clot, perfuse tissue, and vascular resistance. An abnormally high blood viscosity can be an indicator of underlying health issues and a predictor of adverse events such as COVID19, Diabetes, & more.
We review the non-Newtonian response of protein solutions under steady shear and discuss options for interpretation.
We illustrate how defining delivery options and measuring viscosity early in the formulation process will ensure that the appropriate excipients are added to the buffer and the desired result is achieved.
Featuring University of Texas at Austin, we cover why viscosity reduction occurs and how to detect the presence through shear dependent rheology methods.
Designed to be a more sensitive and progressing viscometer, VROC® intium is packed with intelligence and intuition that enables the end users to measure not just viscosity measurements but to use viscosity to provide insight into their product performance and application.
This webinar will show a brief demonstration of the m-VROC® viscometer. Learn how to use small sample sizes and see the different configurations that can be plugged with the viscometer!
This webinar will be helpful for people curious about viscosity (like us!), those who are just starting to use viscosity for their work or want to refresh their knowledge about basic concepts of viscosity!
We demonstrate our technology capability to overcome some of the challenges encountered by conventional methods to measure viscosity when dealing with blood samples.
We trace the historical development of viscosity and viscometers; starting with the fundamental principles established by Sir Isaac Newton and leading up to modern-day viscometry methods.
We demonstrate how VROC® technology can be used to study applications such as protein structure (i.e. denaturation and folding) at a fraction of the sample volume required by conventional technologies.
We address how the rheological behavior of both Newtonian and non-Newtonian therapeutics can help determine injectability in the initial stages of product development.
We explain the differences between Newtonian and non-Newtonian fluids and the fundamentals on establishing the viscosity fingerprint of materials using real application examples.
2420 Camino Ramon, Suite 240
San Ramon, CA 94583